Foster And Thrive Tioconazole Ointment
Product Images NDC 70677-1224
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Foster And Thrive Tioconazole (NDC 70677-1224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strategic Sourcing Services Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 02)
Figure 2 (Image 03)
Figure 3 (Image 04)
Figure 4 (Image 05)
426-km-tioconazole-1-1 (Image 06)
426-km-tioconazole-1-2 (Image 07)
This is a description of a tamper-evident unit containing Ticconazole, which is used to treat vaginal yeast infections. The unit should not be used if the seal is torn, open, or incomplete. It is important to read the enclosed brochure and instructions for complete directions and information before using the product. The product is for vaginal use only and should not be used if the user has never had a vaginal yeast infection diagnosed by a doctor. It is also advised to consult a doctor before using the product if experiencing vaginal itching and discomfort for the first time or if there are other symptoms such as lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. The product should not be used if there is a history of frequent vaginal yeast infections, exposure to HIV, or if pregnant or breastfeeding. Instructions for use and disposal of the applicator are provided. If symptoms do not improve after 3 days, or if they last for more than 7 days, or if there are additional symptoms like a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge, it is recommended to stop using the product and consult a doctor. The product should be kept out of reach of children, and in case of swallowing, medical help or contact with a Poison Control Centre should be sought. The product is a 1-dose treatment, and while most women do not experience complete relief of symptoms in one day, relief is typically experienced within one day and complete relief within 7 days. The product contains inactive ingredients such as butylated hydroxyanisole, magnesium aluminum silicate, and white petrolatum. For any questions or comments, a phone number is provided to contact the manufacturer. The product is distributed by McKesson Corporation and has a money-back guarantee.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.